HOME
PRODUCT
SOLUTION
SUPPORT
SHOP
ABOUT
CONTACT
Optimize Lynch Syndrome screening with Celnovte’s CNT 360. Achieve 98% accuracy and 70% less hands-on time with our automated 4-antibody MMR IHC solutions.
Boost diagnostic accuracy by 20% with Celnovte’s CNT 480 & MicroStacker™. Seamlessly adapt IHC to LBC samples for superior cell adhesion and signal clarity.
Improve diagnostic accuracy in breast cancer with Celnovte’s HER2 solutions. Our sensitive antibodies and automated stainers clarify the HER2-low gray area.
Discover why EBER ISH outperforms IHC for Gastric Cancer diagnosis. Explore Celnovte’s Super-ISH™ probes and CNT 360 for high-precision EBV detection.
Celnovte automated LBC staining systems boost efficiency, precision, and accuracy in cervical cancer screening, offering faster results and reliable diagnoses.
MicroStacker™ technology enhances IHC sensitivity, reduces background noise, and improves antigen detection, making it ideal for tumors and complex diagnostics.
Explore how automated high-throughput IHC and ISH systems improve accuracy, speed up TAT, and power large-scale cancer diagnostics in modern clinical centers.
Learn the clinical implications of an ER-positive diagnosis in breast cancer. Discover the role of ER testing in treatment decisions and patient outcomes.
Explore IHC markers like ER, PR, HER2, and MMR in cancer diagnostics. Learn about their role in disease classification, treatment guidance, and lab innovations.
